Streptococcus anginosus: Difference between revisions
(Created page with "==Background== ==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== {| class="wikitable" | align="center" style="background:#f0f0f0;"|'''Organis...") |
|||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== | ||
{| class="wikitable" | {| class="wikitable" | ||
| align="center" style="background:#f0f0f0;"|'''Organisms''' | | align="center" style="background:#f0f0f0;"|'''Organisms''' |
Revision as of 20:45, 25 March 2014
Background
Antibiotic Sensitivities[1]
Organisms | ' | Strep. milleri |
Penicillins | Penicillin G | + |
Penicillin V | + | |
Anti-Staphylocccal Penicillins | Methicillin | + |
Nafcillin/Oxacillin | + | |
Cloxacillin/Diclox. | + | |
Amino-Penicillins | AMP/Amox | + |
Amox/Clav | + | |
AMP-Sulb | + | |
Anti-Pseudomonal Penicillins | Ticarcillin | + |
Ticar-Clav | + | |
Pip-Taxo | + | |
Carbapenems | Piperacillin | + |
Doripenem | + | |
Ertapenem | + | |
Imipenem | + | |
Meropenem | + | |
Aztreonam | 0 | |
Fluroquinolones | Ciprofloxacin | 0 |
Ofloxacin | 0 | |
Pefloxacin | ||
Levofloxacin | + | |
Moxifloxacin | + | |
Gemifloxacin | + | |
Gatifloxacin | + | |
1st G Cephalosporin | Cefazolin | |
2nd G. Cephalosporin | Cefotetan | |
Cefoxitin | ||
Cefuroxime | ||
3rd/4th G. Cephalosporin | CefoTAXime | |
Cefizoxime | ||
CefTRIAXone | ||
Ceftobiprole | ||
Ceftaroline | ||
CefTAZidime | ||
Cefepime | ||
Oral 1st G. Cephalosporin | Cefadroxil | |
Cephalexin | ||
Oral 2nd G. Cephalosporin | Cefaclor/Loracarbef | |
Cefproxil | ||
Cefuroxime axetil | ||
Oral 3rd G. Cephalosporin | Cefixime | |
Ceftibuten | ||
Cefpodox/Cefdinir/Cefditoren | ||
Aminoglycosides | Gentamicin | |
Tobramycin | ||
Amikacin | ||
Chloramphenicol | ||
Clindamycin | ||
Macrolides | Erythromycin | |
Azithromycin | ||
Clarithromycin | ||
Ketolide | Telithromycin | |
Tetracyclines | Doxycycline | |
Minocycline | ||
Glycylcycline | Tigecycline | |
Glyco/Lipoclycopeptides | Vancomycin | |
Teicoplanin | ||
Telavancin | ||
Fusidic Acid | ||
Trimethoprim | ||
TMP-SMX | ||
Urinary Agents | Nitrofurantoin | |
Fosfomycin | ||
Other | Rifampin | |
Metronidazole | ||
Quinupristin dalfoppristin | ||
Linezolid | ||
Daptomycin | ||
Colistimethate |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
|
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2010